[Federal Register Volume 88, Number 17 (Thursday, January 26, 2023)]
[Notices]
[Page 5008]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01566]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Statement of Organization, Functions, and Delegations of 
Authority

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA), Office of Operations 
(OO), Office of Enterprise Management Services (OEMS) has modified its 
structure. This new organizational structure was approved by the Deputy 
Secretary of Health and Human Services on September 26, 2022, and 
effective on September 26, 2022.

FOR FURTHER INFORMATION CONTACT: Tiffany Branch, Associate Director for 
Management, Office of Enterprise Management Services, Office of 
Operations, Food and Drug Administration, 3 White Flint North, 11601 
Landsdown Street, North Rockville, MD 20852, 240-402-3156.

SUPPLEMENTARY INFORMATION:

I. Introduction

    Part D, Chapter D-B, (Food and Drug Administration), the Statement 
of Organization, Functions and Delegations of Authority for the 
Department of Health and Human Services (35 FR 3685, February 25, 1970, 
60 FR 56606, November 9, 1995, 64 FR 36361, July 6, 1999, 72 FR 50112, 
August 30, 2007, 74 FR 41713, August 18, 2009, 76 FR 45270, July 28, 
2011, and 84 FR 22854, May 20, 2019) is amended to reflect 
reorganization of OEMS.
    This reorganization realigned the FDA History Office function from 
the Office of the Commissioner (OC), Office of External Affairs (OEA) 
to OO, OEMS and revised the OEA and OEMS functional statements to this 
function realignment.
    The Food and Drug Administration, Office of Operations, Office of 
Enterprise Management Services has been restructured as follows:
    DCNA. ORGANIZATION. OEMS is headed by the Director of Enterprise 
Management Services and includes the following organizational units:
Division of Compliance and Conflict Prevention
Division of Human Capital
Division of Information Governance
    FDA History Office
Division of Resources Management
Division of Vendor Management

II. Delegations of Authority

    Pending further delegation, directives, or orders by the 
Commissioner of Food and Drugs, all delegations and redelegations of 
authority made to officials and employees of affected organizational 
components will continue in them or their successors pending further 
redelegations, provided they are consistent with this reorganization.

III. Electronic Access

    This reorganization is reflected in FDA's Staff Manual Guide (SMG). 
Persons interested in seeing the complete SMG can find it on FDA's 
website at: https://www.fda.gov/AboutFDA/ReportsManualsForms/StaffManualGuides/default.htm.

(Authority: 44 U.S.C. 3101).

Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023-01566 Filed 1-25-23; 8:45 am]
BILLING CODE 4164-01-P